RT-qPCR study on post-mortem brain samples from patients with major psychiatric disorders: Reference genes and specimen characteristics

Journal of Psychiatric Research

Volumn 45, Issue 11, 2011, Pages 1411-1418

  Abasolo, Nerea ^a   Torrell, Helena ^a   Roig, Bàrbara ^a   Moyano, Sílvia ^a   Vilella, Elisabet ^a   Martorell, Lourdes ^a  

^a IISPV   (Spain)

Author keywords

Bipolar disorder; Major depressive disorder; Post mortem human brain; Reference genes; RNA quality indicator; Schizophrenia

Indexed keywords

GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; RIBOSOME PROTEIN; RNA; RPL30 PROTEIN; RPLP0 PROTEIN; RPS17 PROTEIN; TRANSFERRIN RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; BIPOLAR DISORDER; BRAIN; CONTROLLED STUDY; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC SCREENING; HUMAN; HUMAN TISSUE; MAJOR DEPRESSION; POST MORTEM MYOLIQUEFACTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHIZOPHRENIA;

EID: 80053949333     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2011.06.001     Document Type: Article

References (31)

1. Andersen C.L., Jensen J.L., Orntoft T.F. Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Research 2004, 64:5245-5250.
2. Atz M., Walsh D., Cartagena P., Li J., Evans S., Choudary P., et al. Methodological considerations for gene expression profiling of human brain. Journal of Neuroscience Methods 2007, 163:295-309.
3. Ben-Shachar D., Karry R. Neuroanatomical pattern of mitochondrial complex I pathology varies between schizophrenia, bipolar disorder and major depression. PloS One 2008, 3:e3676.
4. Birdsill A.C., Walker D.G., Lue L., Sue L.I., Beach T.G. Postmortem interval effect on RNA and gene expression in human brain tissue. Cell and Tissue Banking 2010 Aug 12, [Epub ahead of print].
5. Bray N.J. Gene expression in the etiology of schizophrenia. Schizophrenia Bulletin 2008, 34:412-418.
6. Bustin S.A., Benes V., Garson J.A., Hellemans J., Huggett J., Kubista M., et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clinical Chemistry 2009, 55:611-622.
7. Chana G., Landau S., Beasley C., Everall I.P., Cotter D. Two-dimensional assessment of cytoarchitecture in the anterior cingulate cortex in major depressive disorder, bipolar disorder, and schizophrenia: evidence for decreased neuronal somal size and increased neuronal density. Biological Psychiatry 2003, 53:1086-1098.
8. Chevyreva I., Faull R.L., Green C.R., Nicholson L.F. Assessing RNA quality in postmortem human brain tissue. Experimental and Molecular Pathology 2008, 84:71-77.
9. Fleige S., Pfaffl M.W. RNA integrity and the effect on the real-time qRT-PCR performance. Molecular Aspects of Medicine 2006, 27:126-139.
10. Green E.K., Grozeva D., Jones I., Jones L., Kirov G., Caesar S., et al. The bipolar disorder risk allele at CACNA1C also confers risk of recurrent major depression and of schizophrenia. Molecular Psychiatry 2010, 15:1016-1022.
11. Johnston-Wilson N.L., Sims C.D., Hofmann J.P., Anderson L., Shore A.D., Torrey E.F., et al. Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder. The Stanley neuropathology consortium. Molecular Psychiatry 2000, 5:142-149.
12. Katsel P., Davis K.L., Gorman J.M., Haroutunian V. Variations in differential gene expression patterns across multiple brain regions in schizophrenia. Schizophrenia Research 2005, 77:241-252.
13. Knight H.M., Pickard B.S., Maclean A., Malloy M.P., Soares D.C., McRae A.F., et al. A cytogenetic abnormality and rare coding variants identify ABCA13 as a candidate gene in schizophrenia, bipolar disorder, and depression. American Journal of Human Genetics 2009, 85:833-846.
14. Koppelkamm A., Vennemann B., Fracasso T., Lutz-Bonengel S., Schmidt U., Heinrich M. Validation of adequate endogenous reference genes for the normalisation of qPCR gene expression data in human post mortem tissue. International Journal of Legal Medicine 2010, 124:371-380.
15. Lipska B.K., Deep-Soboslay A., Weickert C.S., Hyde T.M., Martin C.E., Herman M.M., et al. Critical factors in gene expression in postmortem human brain: focus on studies in schizophrenia. Biological Psychiatry 2006, 60:650-658.
16. Liu J., Li J., Li T., Wang T., Li Y., Zeng Z., et al. CTLA-4 confers a risk of recurrent schizophrenia, major depressive disorder and bipolar disorder in the Chinese Han population. Brain, Behavior, and Immunity 2011, 25:429-433.
17. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
18. McCullumsmith R.E., Meador-Woodruff J.H. Striatal excitatory amino acid transporter transcript expression in schizophrenia, bipolar disorder, and major depressive disorder. Neuropsychopharmacology 2002, 26:368-375.
19. Mexal S., Berger R., Adams C.E., Ross R.G., Freedman R., Leonard S. Brain pH has a significant impact on human postmortem hippocampal gene expression profiles. Brain Research 2006, 1106:1-11.
20. Muller N., Schwarz M.J. A psychoneuroimmunological perspective to Emil Kraepelins dichotomy: schizophrenia and major depression as inflammatory CNS disorders. European Archives of Psychiatry and Clinical Neuroscience 2008, 258(Suppl. 2):97-106.
21. Peralta V., Cuesta M.J. Exploring the borders of the schizoaffective spectrum: a categorical and dimensional approach. Journal of Affective Disorders 2008, 108:71-86.
22. Reynolds L.M., Reynolds G.P. Differential regional N-acetylaspartate deficits in postmortem brain in schizophrenia, bipolar disorder and major depressive disorder. Journal of Psychiatric Research 2011, 45:54-59.
23. Rollins B., Martin M.V., Sequeira P.A., Moon E.A., Morgan L.Z., Watson S.J., et al. Mitochondrial variants in schizophrenia, bipolar disorder, and major depressive disorder. PloS One 2009, 4:e4913.
24. Silberberg G., Baruch K., Navon R. Detection of stable reference genes for real-time PCR analysis in schizophrenia and bipolar disorder. Analytical Biochemistry 2009, 391:91-97.
25. Tomita H., Vawter M.P., Walsh D.M., Evans S.J., Choudary P.V., Li J., et al. Effect of agonal and postmortem factors on gene expression profile: quality control in microarray analyses of postmortem human brain. Biological Psychiatry 2004, 55:346-352.
26. Torrey E.F., Webster M., Knable M., Johnston N., Yolken R.H. The Stanley foundation brain collection and neuropathology consortium. Schizophrenia Research 2000, 44:151-155.
27. Van Os J., Jones P., Sham P., Bebbington P., Murray R.M. Risk factors for onset and persistence of psychosis. Social Psychiatry and Psychiatric Epidemiology 1998, 33:596-605.
28. Vandesompele J., De Preter K., Pattyn F., Poppe B., Van Roy N., De Paepe A., et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biology 2002, 3. RESEARCH0034.
29. VanGuilder H.D., Vrana K.E., Freeman W.M. Twenty-five years of quantitative PCR for gene expression analysis. BioTechniques 2008, 44:619-626.
30. Weickert C.S., Sheedy D., Rothmond D.A., Dedova I., Fung S., Garrick T., et al. Selection of reference gene expression in a schizophrenia brain cohort. The Australian and New Zealand Journal of Psychiatry 2010, 44:59-70.
31. Wierschke S., Gigout S., Horn P., Lehmann T.-N., Dehnicke C., Bräuer A.U., et al. Evaluating reference genes to normalize gene expression in human epileptogenic brain tissues. Biochemical and Biophysical Research Communications 2010, 403:385-390.